Wells Fargo & Company »

Protalix Biotherapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $36k 20k 1.78
2023-09-30 $26k 16k 1.66
2023-06-30 $42k 21k 2.00